|
|
|
|
|
|
|
M Tue W Th F |
|
1 September, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
At this point, we know how these 'most favored nation' deals shape up. And yesterday, it was who wasn't there that stuck out to me. Some of the largest mid-cap companies sat out this round, and at least one company not in attendance said that, actually, it has a pricing deal as well.
I was also interested to hear an update on the CMS bridge program as well as from Trump's new FDA pick. I detail those takeaways in my story this afternoon. |
|
|
|
Max Bayer |
Senior Reporter, Endpoints News
|
|
|
|
 |
|
Company executives joined President Donald Trump and top health officials at a drug pricing event on Monday. (Credit: AP Photo/Jacquelyn Martin) |
|
|
|
by Max Bayer
|
President Donald Trump announced voluntary drug pricing deals with nine new companies on Monday, for the first time veering outside of the original crop of... | |
|
|
|
|
|
|
by Ryan Cross
|
The dream of making personalized genetic medicines at a moment’s notice just got a major infusion of funding from the federal government. Five groups were... | |
|
|
|
|
|
|
by Anna Brown
|
Roughly a year after shedding half of its workforce, Arsenal Biosciences is trimming its headcount again by letting go of “the majority” of its staffers... | |
|
|
|
|
|
|
by Nicole DeFeudis
|
Three patients died in Novartis trials of its CD19-directed CAR-T treatment following a dangerous immune system response, and a similar therapy from Bristol Myers Squibb... | |
|
|
|
|
|
|
|
|
by Kyle LaHucik
|
At least 50 different venture investors have benefited from Eli Lilly’s dealmaking this year, sending early investment dollars back into the startup ecosystem. On Monday... | |
|
|
|
|
|
|
by Reynald Castaneda
|
GSK on Tuesday said it will start a late-stage trial of its mRNA vaccine for seasonal influenza after the candidate delivered “higher immune responses” than... | |
|
|
|
|
|
